NasdaqGS - Delayed Quote USD

Akero Therapeutics, Inc. (AKRO)

20.14 +0.22 (+1.10%)
At close: 4:00 PM EDT
20.14 0.00 (0.00%)
After hours: 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
204,071.00
172,870.00
115,156.00
100,886.00
80,154.00
Operating Income
-204,071.00
-172,870.00
-115,156.00
-100,886.00
-80,154.00
Net Non Operating Interest Income Expense
24,799.00
21,111.00
3,123.00
109.00
--
Other Income Expense
--
--
3,862.00
109.00
947.00
Pretax Income
-179,272.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Net Income Common Stockholders
-179,272.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Diluted NI Available to Com Stockholders
-179,272.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Basic EPS
-3.24
-2.89
-2.87
-2.89
-2.52
Diluted EPS
-3.24
-2.89
-2.87
-2.89
-2.52
Basic Average Shares
55,659.08
52,568.16
38,984.77
34,827.39
31,463.25
Diluted Average Shares
55,659.08
52,568.16
38,984.77
34,827.39
31,463.25
Total Operating Income as Reported
-204,071.00
-172,870.00
-115,156.00
-100,886.00
-80,154.00
Total Expenses
204,071.00
172,870.00
115,156.00
100,886.00
80,154.00
Net Income from Continuing & Discontinued Operation
-179,272.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Normalized Income
-179,272.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Interest Income
28,432.00
24,210.00
3,862.00
109.00
--
Interest Expense
3,633.00
3,099.00
739.00
--
--
Net Interest Income
24,799.00
21,111.00
3,123.00
109.00
--
EBIT
-175,639.00
-148,660.00
-111,294.00
-100,777.00
-80,154.00
EBITDA
-175,620.00
-148,631.00
-111,251.00
-100,736.00
-80,137.00
Reconciled Depreciation
19.00
29.00
43.00
41.00
17.00
Net Income from Continuing Operation Net Minority Interest
-179,272.00
-151,759.00
-112,033.00
-100,777.00
-79,207.00
Normalized EBITDA
-175,620.00
-148,631.00
-111,251.00
-100,736.00
-80,137.00
12/31/2020 - 6/20/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ETNB 89bio, Inc.
8.94
+3.59%
 
STOK Stoke Therapeutics, Inc.
16.10
+15.83%
 
MDGL Madrigal Pharmaceuticals, Inc.
232.10
+5.47%
 
CABA Cabaletta Bio, Inc.
12.88
+4.29%
 
PLRX Pliant Therapeutics, Inc.
15.12
-0.98%
 
ALEC Alector, Inc.
5.41
-0.55%
 
RVMD Revolution Medicines, Inc.
40.03
+1.57%
 
BDTX Black Diamond Therapeutics, Inc.
4.9000
+0.62%
 
VTYX Ventyx Biosciences, Inc.
4.8300
+2.11%
 
IMVT Immunovant, Inc.
30.87
+0.55%